D. Boral Capital Acted as Financial Advisor to Clene Inc. (Nasdaq: CLNN) in Connection with its $7,000,000 Underwritten Registered Direct Offering
Transaction Information On May 5, 2026, Clene Inc. (Nasdaq: CLNN) and its wholly owned subsidiary, Clene Nanomedicine, Inc., a late










